FDAINTENTTOSOLESOURCEBRIDGESENTINEL2
Sentinel System Bridge Contract
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
Archived
Quick analysis
This notice appears to be an Award Notice tied to a J&A/JOFOC for a sole-source bridge action for FDA/CDER’s “Sentinel 2.0” effort; the only attachment is unreadable, leaving critical details unknown.
Based on the Scout ledger and metadata, access is effectively closed (sole-source bridge) and outside Trace’s core DoD-centric lanes; no relevant past performance with FDA/HHS is documented in the company profile.
No Trace-held prime vehicle aligns here, and competitive position is untenable against an unnamed incumbent. Given the unreadable J&A and lack of access, this is not a viable pursuit.
Scope summary
- Sole-source bridge action per J&A/JOFOC (inferred from filename and notice description).
- Agency: FDA Office of Acquisition & Grant Services; likely within CDER context (from filename).
- Place of performance: Canton, MA 02021 (from metadata).
- No set-aside (full & open in principle, but constrained by J&A).
Dimension scores
Total
- 5/100
Technical Fit
- 2/20
Metadata and classification code B537 suggest medical/health R&D/professional services for FDA/CDER, not Trace’s core lanes (SATCOM, CDS/MPE, JADC2, edge, OCC). No evidence in the ledger or metadata ties this to Trace core capabilities.
Past Performance
- 1/20
Company profile lists DoD-centric past performance (DISA, USAF, USSF, Army, MDA). No evidence of FDA/HHS past performance. New customer and mission area per provided materials.
Vehicles / Contract Access
- 0/10
Notice is an Award Notice referencing a J&A/JOFOC for a sole-source bridge; not issued on a Trace prime vehicle and not full/open. Access appears closed to the named source.
Competitive Position
- 0/15
Sole-source bridge implies an incumbent advantage. Trace is not identified as incumbent, and no differentiator is requested. Competitive position is effectively non-viable.
Risk
- 1/15
Very high pursuit risk: sole-source J&A limits access; unreadable attachment withholds critical details (incumbent, scope, PoP). New civilian agency context adds uncertainty.
Strategic Value
- 0/10
No clear strategic value supported by evidence. FDA/HHS is not listed as a target agency; this does not expand a stated strategic lane, and access is closed.
Compliance
- 1/10
Set-aside is NONE (Trace eligible), but the sole-source J&A effectively requires being the named source, which Trace is not. Without being the specified vendor, compliance to access is not met.
Concerns
- Access closed due to sole-source J&A/JOFOC; incumbent lock-in likely.
- Unreadable J&A prevents confirmation of incumbent, scope, PoP, and period of performance.
- Non-target civilian health domain outside Trace core delivery lanes.
- Award Notice suggests no response window or bid path.
Teaming opportunities
- Prime access appears limited to the named source in the J&A; incumbent identity unknown due to unreadable file.
- No identified civilian health analytics/RWE partner or incumbent relationship evidenced in materials.
Competitive position
- No actionable win themes identified; opportunity appears closed and misaligned with Trace core differentiators.
Bid/No bid factors
- Award Notice with J&A/JOFOC indicates sole-source bridge.
- Only attachment unreadable/restricted; critical details unavailable.
- Non-target agency (FDA/HHS) with no documented Trace past performance.
- Not on a Trace prime vehicle.
- NAICS listed as 3-digit ‘541’ in metadata; scope ambiguity remains due to unreadable J&A.
Documents
Download all
JA JOFOC CDER Sentinel 2.0 Bridge 2 25 2026 word 2 26 2026.pdf
Download
JA JOFOC CDER Sentinel 2.0 Bridge 2 25 2026 word 2 26 2026.pdf
Download
Restricted: Unreadable
Summary
The PDF is unreadable in the ingestion: only filename and metadata are available. The filename explicitly contains 'JA' and 'JOFOC' plus 'CDER Sentinel 2.0 Bridge' with a 2/25/2026 date, but the document contents could not be extracted for review due to the file being restricted/unreadable.
- Filename includes 'JA' and 'JOFOC' and 'CDER Sentinel 2.0 Bridge' (date 2/25/2026) — suggests this is a Justification & Approval / JOFOC for the Sentinel 2.0 bridge action (document-level clue only).
- Ingestion status: processing_mode=metadata_only; extractor pending and review_status=restricted — no textual content available for analysis.
- Opportunity metadata description references 'See J and A Attachment' — this file likely is that attachment, so it may contain sole-source justification and acquisition rationale if it were readable.
- Because the document is unreadable, critical details that would affect Trace scoring are unavailable here (e.g., sole-source rationale, incumbent identity, period of performance, deliverables, funding, constraints, place-of-performance specifics beyond opportunity metadata).
- Place-of-performance and customer context must be taken from opportunity metadata (FDA / CDER; Canton, MA ZIP 02021) rather than this file due to unreadability.
Technical details
Entry: sync
Review status: Up to date
Logical upstream opportunity: 6696
Notice lineage:
- f86614edda504dcc9ab23d3cac387b88 (posted 2026-03-30) - current
- 3cd079dfc54a44748690dcb21720eaef
- c809bd7e3b4c44ab945b710b1c9f8569
Last synced: 2026-03-30T17:52:39.922210+00:00
Last analyzed: 2026-03-30T17:53:56.066825+00:00
Latest package fingerprint: 355be1b5801c7e20c33f2821535826dabd75f9b9cdc55c2797a3b901744f34f1
Latest package notice: f86614edda504dcc9ab23d3cac387b88
Latest package documents: 1
Evidence limitations- JA JOFOC CDER Sentinel 2.0 Bridge 2 25 2026 word 2 26 2026.pdf: restricted (unreadable)
- Documents exist upstream, but no usable document text was available yet; Scout analyzed metadata only.
- 2026-03-30T17:52:39.925523+00:00: f86614edda504dcc9ab23d3cac387b88 with 1 docs
Labels
Human notes
No human notes yet.